5 years ago

Aspect Biosystems Raises $20 Million for 3D Bioprinting of Human Tissues

  • Aspect Biosystems, a Canadian biotechnology company specializing in 3D bioprinting of human tissues, has secured $20 million in Series A funding led by Radical Ventures

  • The funding will be used to advance tissue therapeutic programs, expand technology platform capabilities, and grow the team

  • The company's technology enables the creation of living human tissues with unprecedented control and precision, aiming to transform medical research and clinical practice.

      • ProblemHealthcare

      "Aspect Biosystems is tackling a global problem in regenerative medicine and therapeutic discovery by developing a technology platform that enables the creation of living human tissues with unprecedented control, flexibility, and precision."

      Solution

      "Through its microfluidic 3D bioprinting technology, Aspect Biosystems is creating high-value solutions that help transform medical research and clinical practice, enabling the development of breakthrough treatments for various diseases and conditions."

      Covered on